Ignite Creation Date:
2024-05-06 @ 3:10 AM
Last Modification Date:
2024-10-26 @ 11:29 AM
Study NCT ID:
NCT02229149
Status:
TERMINATED
Last Update Posted:
2022-12-02
First Post:
2014-08-27
Brief Title:
Phase 2 Study of Standard Chemotherapy With Trastuzumab Plus or Minus Pertuzumab for Pre-treated Metastatic Breast Cancer
Sponsor:
US Oncology Research
Organization:
US Oncology Research
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01
Completion Date Type:
ACTUAL
First Submit Date:
2014-08-27
First Submit QC Date:
August 28 2014
Study First Post Date:
2014-08-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-29
Last Update Post Date:
2022-12-02
Last Update Post Date Type:
ACTUAL